Question 1

What are digital therapeutics?

Accepted Answer

Digital therapeutics are FDA-cleared software applications that treat diseases like traditional medicine. Unlike wellness apps that simply track symptoms, these platforms deliver actual therapeutic interventions through clinically validated apps that undergo the same rigorous trials as conventional drugs, earning prescription status and insurance coverage.

Question 2

How do digital therapeutics differ from health apps?

Accepted Answer

Digital therapeutics undergo rigorous clinical trials and FDA approval, while regular health apps don't require regulatory clearance. These therapeutic platforms deliver evidence-based medical interventions - like adjusting insulin recommendations in real-time or providing personalized cognitive behavioral therapy - rather than just tracking health metrics.

Question 3

What does FDA-cleared software mean?

Accepted Answer

FDA-cleared software means the application has been reviewed and approved by the Food and Drug Administration as a medical device. These digital therapeutics must meet the same safety and efficacy standards as traditional pharmaceuticals, including conducting randomized controlled trials and publishing peer-reviewed research before gaining approval.

Question 4

How to invest in digital therapeutics stocks?

Accepted Answer

You can invest in digital therapeutics through companies like DARIOHEALTH CORP (DRIO), Teladoc Inc (TDOC), and Hims & Hers Health Inc (HIMS). These stocks are available through regulated platforms like Nemo, offering commission-free trading and fractional shares starting from $1 to make investing accessible.

Question 5

Are digital therapeutics stocks risky?

Accepted Answer

Digital therapeutics investments carry significant risks including uncertain regulation, adoption barriers, and intense competition. Many companies are still developing products or securing regulatory approvals. However, successful companies with FDA-cleared products and insurance coverage have significantly de-risked their business models compared to development-stage firms.

Question 6

Best digital therapeutics companies to invest in?

Accepted Answer

Leading digital therapeutics companies include DARIOHEALTH CORP (DRIO) for chronic conditions like diabetes, Teladoc Inc (TDOC) for comprehensive digital care delivery, and Hims & Hers Health Inc (HIMS) for direct-to-patient digital treatments. These companies represent different approaches within the growing digital therapeutics sector.

Question 7

Do digital therapeutics stocks pay dividends?

Accepted Answer

Most digital therapeutics companies are growth-stage firms focused on expanding their platforms and securing regulatory approvals, so they typically don't pay dividends. These companies reinvest profits into research, development, and market expansion to capture the significant growth opportunities in this emerging healthcare sector.

Question 8

Why are digital therapeutics growing now?

Accepted Answer

Digital therapeutics are accelerating due to rising healthcare costs, healthcare professional shortages, and changing patient preferences toward app-based services. The COVID-19 pandemic normalized digital healthcare delivery, while insurance companies increasingly cover these treatments, recognizing their clinical effectiveness and cost advantages over traditional therapies.

Question 9

Do insurance companies cover digital therapeutics?

Accepted Answer

Yes, major insurers are increasingly covering digital therapeutics for specific conditions, recognizing both their clinical effectiveness and cost advantages. This reimbursement shift unlocks enormous revenue potential, allowing companies to access the broader healthcare market where insurance coverage drives adoption rather than relying on direct-pay models.

Question 10

What drives digital therapeutics market growth?

Accepted Answer

Key growth drivers include healthcare cost pressures creating demand for scalable treatments, healthcare professional shortages making digital solutions attractive, and technology improvements in mobile devices and AI enabling sophisticated interventions. Patient preferences are also shifting toward app-based healthcare, especially among younger demographics.

Question 11

How to buy digital therapeutics stocks on Nemo?

Accepted Answer

You can invest in digital therapeutics stocks through Nemo's ADGM-regulated platform, which offers commission-free investing and fractional shares starting from $1. The platform provides AI-driven research and access to companies like DRIO, TDOC, and HIMS, making theme-based investing in healthcare innovation accessible to all investors.

Software as Medicine: The Digital Therapeutics Revolution

Software as Medicine: The Digital Therapeutics Revolution

Tesla's Deliveries Beat Masks a Deeper Demand Story

Why Washington Just Bet $4.2 Billion on Vistra's Reactors

Toshiba's HDD Surge Rattles Seagate and Western Digital

Rivian's Delivery Surge Can't Shake Investor Jitters

Why ON Semiconductor Is Betting $5.7bn on the Edge

Your Next Prescription Might Just Be an App

The Medicine Cabinet Gets a Software Update

Follow the Money, Follow the Insurers

The Companies Carving Out a Niche

A Healthy Dose of Scepticism

Deep Dive

Market & Opportunity

Key Companies

Primary Risk Factors

Growth Catalysts

How to invest in this opportunity

Frequently Asked Questions

Recent insights

Tesla's Deliveries Beat Masks a Deeper Demand Story

Why Washington Just Bet $4.2 Billion on Vistra's Reactors

Toshiba's HDD Surge Rattles Seagate and Western Digital

Rivian's Delivery Surge Can't Shake Investor Jitters

Why ON Semiconductor Is Betting $5.7bn on the Edge

Tesla's Deliveries Beat Masks a Deeper Demand Story

Why Washington Just Bet $4.2 Billion on Vistra's Reactors

Toshiba's HDD Surge Rattles Seagate and Western Digital

Rivian's Delivery Surge Can't Shake Investor Jitters

Why ON Semiconductor Is Betting $5.7bn on the Edge